DXCM News and Press, DexCom Inc. From 08/29/23

2023-08-29 13:29:41 ET More on IHI IHI: Too Expensive Considering Long-Term Rate Uncertainty Johnson & Johnson’s MedTech performance rallies industry Life science tools industry drags healthcare in S&P 500 MedTech, hospital stocks slump after T...

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Rimma Driscoll to its Board of Directors, effective August 24, 2023. Ms. Driscoll is an accomplished leader with significant experience developing, guiding and execu...

2023-08-22 10:00:00 ET The healthcare sector is a hotbed of innovation, and those companies that genuinely break new ground are often handsomely rewarded, along with their shareholders. Investors looking to earn outsized returns over long periods (which describes most investors) would do we...

2023-08-20 12:15:42 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The latest jobs report showed a slowing pace of hiring which will affect stock market opportunities. The July jobs report showed slowing hiring with low unemployment. The economy continues to c...

Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (rtCGM), is proud to announce that for the second consecutive year, it has been certified as a Great Place to Work ® in Canada for 2023-24. Awarded by Great Place to Work Institute ® , the glo...

2023-08-13 23:31:51 ET Summary Wegovy and Mounjaro obesity and diabetes drugs are expected to have a significant impact on society and may lead to a decrease in demand for certain medical devices and surgeries. Medical device stocks, such as Shockwave, DexCom, and Intuitive Surgic...

2023-08-10 08:55:06 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Uncertainty from geopolitical tensions within the Ukraine war and China issues has led to slower United States labor market growth . In this environment of uncertainty, the United...

2023-08-09 09:00:00 ET One of the great things about investing in stocks is that there is no need to have millions in the bank to get started. A relatively modest sum such as $1,000 can go a long way if invested shrewdly. But with an abundance of options to choose from, it can be challengin...

2023-07-31 21:16:08 ET Summary DexCom posted strong results for 2Q23, with revenues of $871 million and EPS beating expectations. The company gained new customers and expanded its market share in the United States, particularly in the Type 2 Basal segment. Medicare coverage fo...

2023-07-31 13:14:31 ET Summary Baillie Gifford's 13F portfolio value increased from ~$111B to ~$118B this quarter. The top three holdings are MercadoLibre, NVIDIA, and Tesla Motors, which make up ~17% of the portfolio. Baillie Gifford made stake increases in MercadoLibre, PDD ...